TY  - GEN
AU  - Simons,W Robert
AU  - Hagan,Michael A
TI  - An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus
SN  - 1179-2027
PY  - 2011///0131
KW  - Adult
KW  - Aged
KW  - Allylamine
KW  - administration & dosage
KW  - Cardiovascular Diseases
KW  - economics
KW  - Cholesterol, LDL
KW  - blood
KW  - Colesevelam Hydrochloride
KW  - Cost-Benefit Analysis
KW  - methods
KW  - Databases, Factual
KW  - Diabetes Complications
KW  - Diabetes Mellitus, Type 2
KW  - Drug Therapy, Combination
KW  - Female
KW  - Glycated Hemoglobin
KW  - metabolism
KW  - Health Care Costs
KW  - Humans
KW  - Hypercholesterolemia
KW  - Insulin
KW  - Male
KW  - Metformin
KW  - Middle Aged
KW  - Models, Economic
KW  - Randomized Controlled Trials as Topic
KW  - Risk
KW  - Sulfonylurea Compounds
KW  - Treatment Outcome
KW  - United States
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.2165/11539600-000000000-00000
ER  -